Title: Inducible Small RNA Expression Constructs for Targeted Gene Silencing
Patent Number: 8,198,077
Filed: Jan. 15, 2004
Lead Inventor: Thomas Tuschl, Max Plank Institute
“The invention relates to vectors for the inducible expression of RNA molecules in eukaryotic, particularly mammalian, cells and transgenic animals,” the patent's abstract states.